Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced FDA 510(k) clearance of a full range of Polysite® Implantable Ports for exclusive distribution in the U.S. under its ARROW® brand. These ports have a low profile, hybrid design that combines a lightweight plastic body and a strong titanium reservoir, and will be available in both pressure injectable and non-pressure injectable options.

“The ARROW® Polysite® Low Profile Hybrid Ports will further broaden a product line that demonstrates our commitment to enhance patient outcomes, improve safety and drive health economics in the area of interventional access,” said Linda Beneze, President and General Manager, Specialty Division. “We are proud to add ARROW® Polysite® Ports to our portfolio.”

The ARROW® Polysite® Low Profile Hybrid Ports have a lightweight body with an atraumatic profile designed to provide patient comfort, while the strong titanium reservoir is compatible with a range of cytotoxic drugs commonly used in chemotherapy and prevents needle “pitting” experienced with plastic reservoirs. The ports will be available in 6 Fr. Micro, 7 Fr. Mini, and 8 Fr. Standard sizes with attachable polyurethane catheter. All sizes are pressure injectable up to 5 mL/sec at 300psi and are MR conditional. Each ARROW® Polysite® Port Kit contains a Polyperf SafeTM Safety Huber Needle. This patented positive pressure Huber needle has a removal system designed to reduce the risk of blood reflux and minimize catheter occlusion by maintaining positive flush pressure during one-handed needle removal.

About Perouse Medical

For more information, visit www.perousemedical.com.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,400 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Perouse Medical, Polysite and Polyperf Safe are trademarks or registered trademarks of Perouse Medical.

Teleflex and Arrow are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.

© 2014 Teleflex Incorporated. All rights reserved. 2014-2699

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836

Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Teleflex Charts.
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Teleflex Charts.